Evidence map›Paper›PMID 42105753›Full record

ArticleCurrent biology : CB2026

Teneurin-3 and latrophilin-2 are required for somatotopic map development and somatosensory topognosis.

Kevin T Sangster, Xinying Zhang, Daniel Del Toro, Christina Sarantopoulos, Ashley M Moses, Shreya Mahasenan, Daniel T Pederick, Sophie Perreault, Catherine Fallet-Bianco, R Brian Roome and 3 more

Abstract read
In one paragraph

Article in Current biology : CB, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kevin T SangsterInstitut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 1A1, Canada.
Xinying ZhangInstitut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 1A1, Canada.
Daniel Del ToroDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Institute of Neurosciences, IDIBAPS, CIBERNED, University of Barcelona, 08036 Barcelona, Spain.
Christina SarantopoulosInstitut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 1A1, Canada.
Ashley M MosesDepartment of Biology, Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.
Shreya MahasenanInstitut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada.
Daniel T PederickDepartment of Biology, Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.
Sophie PerreaultAzrieli Research Center at CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada.
Catherine Fallet-BiancoDepartment of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC H3T 1C5, Canada; Department of Pathology and Cell Biology, Université de Montréal, Montréal, QC H3T 1J4, Canada.
R Brian RoomeSpinal Circuits and Plasticity Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.
Elena SeiradakeDepartment of Biochemistry, University of Oxford, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford OX1 3QU, UK.
Liqun LuoDepartment of Biology, Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.
Artur KaniaInstitut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Integrated Program in Neuroscience, McGill University, Montréal, QC H3A 1A1, Canada; Division of Experimental Medicine, McGill University, Montréal, QC H4A 3J1, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, QC H3A 0C7, Canada. Electronic address: artur.kania@ircm.qc.ca.

Funding

Mosaic Analysis with Double Markers in MiceR01NS050835 · NINDS · STANFORD UNIVERSITY · PI LIQUN LUO · 2005 to 2026
$7.3M
NINDS NIH HHS R01 NS050835
6 · The paper itself

Abstract

Somatotopy is a recurring organizational feature of the somatosensory system where adjacent neurons and their connections represent adjacent regions of the body. The molecular mechanisms governing the formation of such "body maps" remain largely unknown. Here, we demonstrate that the cell surface proteins teneurin-3 and latrophilin-2 are expressed in opposing gradients aligning with the somatotopic map in the dorsal horn of the mouse spinal cord. Genetic manipulation of these proteins in the spinal dorsal horn or sensory neurons distorts the somatotopy of neuronal connections and impairs the accurate localization of a noxious stimulus on the surface of the body. Our work provides the foundation for a molecular model of somatotopic map formation and insights into the role of somatotopic maps in the ability to accurately locate somatosensory stimuli, also known as topognosis.

Indexed as

Nerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, PeptideAnimalsMicelatrophilin-2, mouseNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, Peptidecell surface proteinsCSPdevelopmentdorsal hornnociceptionsomatosensory systemsomatotopic mapssomatotopyspinal cordtopognosistopographic maps

Identifiers

PMID42105753
PMCPMC13301496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.